Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

TogoRun appoints Clare Preskett as co-managing director

She will share duties with Jonathan Kearney who has been promoted

- PMLiVE

M3 appoints Paul Rice as chief operating officer

Simon Walker also joins the online doctor communities group

- PMLiVE

Pfizer wins EU approval for MenB vaccine Trumenba

US pharma firm’s injection can now be given to patients aged 10 and above

- PMLiVE

Gilead plans fightback against HIV arch-rival ViiV

Descovy sees phase III success after the TAF-based drug proves non-inferior to Triumeq

So, you want Uber to take you to the hospital?

Why using ride-sharing services in place of ambulance services is a bad idea

Generation Now: the impact of the millennial HCP on our world

Millennials are criticised as narcissistic, entitled and technology-obsessed, but our new campaign shows millennial healthcare professionals – mHCPs – in a different light. They have certainly grown up in a...

Havas Lynx

Novartis building

Novartis’ Zykadia claims US approval for first-line lung cancer

The Swiss pharma giant’s drug also receives CHMP positive opinion

- PMLiVE

Novo seeks to strengthen Tresiba label in US

Studies find insulin degludec advantage over insulin glargine

Rare diseases: meeting the challenge

Problems with regulating orphan drugs

- PMLiVE

FDA panel backs Puma’s breast cancer drug, with reservations

Side effects concerns could see medicines limited

- PMLiVE

Pfizer gets FDA panel recommendation for biosimilar EPO

Product could be the first direct competitor to Epogen and Procrit in the US

- PMLiVE

The false economy of following the leader

How can companies in the sector shake things up?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links